Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans
- PMID: 27558857
- PMCID: PMC10254573
- DOI: 10.1093/pm/pnw140
Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-Prescribing Among Veterans
Abstract
Background: Due to the involvement of opioids and benzodiazepines in rising pharmaceutical overdoses, a reduction in coprescribing of these medications is a national priority, particularly among patients with substance use disorders and other high-risk conditions. However, little is known about primary care (PC) and mental health (MH) prescribers' perspectives on these medications and efforts being implemented to reduce coprescribing.
Design: An anonymous survey.
Setting: One multisite VA health care system.
Subjects: Participants were 55 PC and 31 MH prescribers.
Methods: Survey development was guided by the Promoting Action on Research Implementation in Health Services (PARIHS) conceptual framework. PC and MH prescribers of opioids or benzodiazepines were invited to complete an anonymous electronic survey. Responses were collapsed to highlight agreement, disagreement, and neutrality and summarized with means and percentages.
Results: Over 80% of both prescriber groups reported concern about concurrent use and > 75% strongly agreed with clinical practice guidelines (CPG) that recommend caution in coprescribing among patients with high-risk conditions. More than 40% of both prescriber groups indicated that coprescribing continues because of beliefs that patients appear stable without adverse events and tapering/discontinuation is too difficult. Over 70% of prescribers rated strategies for addressing patients who refuse to discontinue, more time with patients, and identification of high-risk patients as helpful in reducing coprescribing.
Conclusion: Despite strong agreement with CPGs, prescribers reported several barriers that contribute to coprescribing of opioids and benzodiazepines and challenge their ability to taper these medications. Multiple interventions are likely needed to reduce opioid and benzodiazepine coprescribing.
Keywords: Attitudes; Beliefs; Chronic Pain; Concurrent Opioid and Benzodiazepine Use; High-Risk Conditions; Mental Health; Primary Care.
Published by Oxford University Press on behalf of the American Academy of Pain Medicine. 2016. This work is written by US Government employees and is in the public domain in the US.
Conflict of interest statement
Disclosures/Conflicts of Interest
The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or University of Washington.
Figures
Similar articles
-
Electronic Medical Record Alert Associated With Reduced Opioid and Benzodiazepine Coprescribing in High-risk Veteran Patients.Med Care. 2018 Feb;56(2):171-178. doi: 10.1097/MLR.0000000000000861. Med Care. 2018. PMID: 29287034 Free PMC article.
-
An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015.Am J Prev Med. 2019 Nov;57(5):629-636. doi: 10.1016/j.amepre.2019.06.007. Epub 2019 Sep 27. Am J Prev Med. 2019. PMID: 31564606 Free PMC article.
-
Coprescribing of Benzodiazepines and Opioids in Older Adults: Rates, Correlates, and National Trends.J Gerontol A Biol Sci Med Sci. 2019 Nov 13;74(12):1910-1915. doi: 10.1093/gerona/gly283. J Gerontol A Biol Sci Med Sci. 2019. PMID: 30561526 Free PMC article.
-
Opioid Prescribing Patterns and Complications in the Dermatology Medicare Population.JAMA Dermatol. 2018 Mar 1;154(3):317-322. doi: 10.1001/jamadermatol.2017.5835. JAMA Dermatol. 2018. PMID: 29417134 Free PMC article.
-
Development of prescribing indicators related to opioid-related harm in patients with chronic pain in primary care-a modified e-Delphi study.BMC Med. 2024 Jan 2;22(1):5. doi: 10.1186/s12916-023-03213-x. BMC Med. 2024. PMID: 38167142 Free PMC article. Review.
Cited by
-
Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction.J Gen Intern Med. 2020 Mar;35(3):687-695. doi: 10.1007/s11606-019-05445-1. Epub 2020 Jan 6. J Gen Intern Med. 2020. PMID: 31907789 Free PMC article.
-
General practitioners and management of chronic noncancer pain: a cross-sectional survey of influences on opioid deprescribing.J Pain Res. 2019 Jan 22;12:467-475. doi: 10.2147/JPR.S168785. eCollection 2019. J Pain Res. 2019. PMID: 30774416 Free PMC article.
-
"Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications.Pain Med. 2018 Nov 1;19(11):2201-2211. doi: 10.1093/pm/pnx276. Pain Med. 2018. PMID: 29126138 Free PMC article.
-
Electronic Medical Record Alert Associated With Reduced Opioid and Benzodiazepine Coprescribing in High-risk Veteran Patients.Med Care. 2018 Feb;56(2):171-178. doi: 10.1097/MLR.0000000000000861. Med Care. 2018. PMID: 29287034 Free PMC article.
-
Concurrent Use of Opioids with Other Central Nervous System-Active Medications Among Older Adults.Popul Health Manag. 2020 Aug;23(4):286-296. doi: 10.1089/pop.2019.0128. Epub 2019 Nov 25. Popul Health Manag. 2020. PMID: 31765280 Free PMC article.
References
-
- Jones CM, Mack KA, and Paulozzi LJ, Pharmaceutical overdose deaths, United States, 2010. JAMA, 2013. 309(7): p. 657–9. - PubMed
-
- Spitzer C, et al., Association of airflow limitation with trauma exposure and post-traumatic stress disorder. Eur Respir J, 2011. 37(5): p. 1068–75. - PubMed
-
- Williams SG, et al., Sleep disorders in combat-related PTSD. Sleep Breath, 2014. - PubMed
-
- Sehgal N, Colson J, and Smith HS, Chronic pain treatment with opioid analgesics: benefits versus harms of long-term therapy. Expert Rev Neurother, 2013. 13(11): p. 1201–20. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources